BB&T Securities’s Precigen PGEN Stock Holding History

BB&T Securities’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-12,608	Closed	-$175K	–	1623
2018 Q2	$175K	Buy	+12,608	New	+$213K	﹤0.01%	1469

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BB&T Securities's PGEN Position: Q3 2018 in Review

BB&T Securities sold out of Precigen (PGEN) in Q3 2018, closing a stake of 12,608 shares — an estimated $175K sold.

BB&T Securities first reported a position in PGEN in Q2 2018 and held it in 1 quarter. The position peaked at $175K in Q2 2018. 170 funds tracked by Wall St. Rank hold PGEN as of Q3 2018.

BB&T Securities reported no remaining Precigen position as of Q3 2018 after selling out during the quarter.
BB&T Securities sold 12,608 Precigen shares in Q3 2018, an estimated $175K.
BB&T Securities first reported a position in Precigen in Q2 2018 and held it in 1 quarter.
BB&T Securities's Precigen position peaked at $175K in Q2 2018.
170 funds tracked by Wall St. Rank held Precigen as of Q3 2018.

Based on BB&T Securities's 13F filing for Q3 2018, filed 14 Nov 2018.